TP53 and pleomorphic rhabdomyosarcoma: In terms of “rare cancer” as an item of the Chompret criteria, the ratio of individuals with TP53 pathogenic variant is high among patients with adrenocortical cancer and choroid plexus carcinoma, and its reproducibility in embryonal anaplastic rhabdomyosarcoma has not been reported.